December 3, 2025

Bentley’s BeGraft Plus for BEVAR Used in First Clinical Procedure

December 3, 2025—Bentley InnoMed GmbH, which is headquartered in Hechingen, Germany, announced the first-in-human use of the company’s BeGraft Plus, which features a new 77/78-mm length. On November 19, Bentley announced CE Mark approval for the BeGraft Plus for use as a bridging stent graft in branched endovascular aneurysm repair.

The company noted that the procedure, which was performed by Professor Eric Verhoeven, MD, at General Hospital Nuremberg in Nuremberg, Germany, marks the first clinical use of the device after receiving CE Mark approval.

According to Bentley, the extended length broadens the company’s portfolio of dedicated solutions, supporting anatomies where additional coverage is required and allows physicians to match the graft more precisely to the clinical situation.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

December 3, 2025

Bentley’s BeGraft Plus for BEVAR Used in First Clinical Procedure

Current Issue

Keep In Touch